Webvent

SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Healthcare Research Network - Chicago

Phase II & Phase III Clinical Research - Focusing in Prevalent Chronic Conditions

Healthcare Research Network - Chicago

Healthcare Research Network - St. Louis is an elite Clinical Research Site Network comprised of private physicians from multiple specialties that conduct clinical research studies.  Our focus is in Phase IIB – Phase IV clinical research.  Our concentration is in prevalent chronic conditions.  We were founded in 1998 and have successfully completed over 1000 trials.  Our randomization to contractual commitment ration is 108% over the last 5 years. 


Our therapeutic focus and research experience includes the following: 
• Chronic Pain
• Osteoarthritis 
• Rheumatology (RA, Gout)
• Endocrinology (Diabetes and Metabolic Disorders)
• Asthma/Allergy
• Pulmonary Diseases
• Gastrointestinal (IBS, Ulcerative Colitis, Crohn's Disease)
• Oncology
• Hematology
• Neurological Disorders
• Psychiatry
 

Study Search 

Information

Demographic Data

  • SITE INFORMATION 
  • Start year clinical research1998
  • Phases of clinical studiesPhase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • SPECIFIC SITE INFORMATION 
  • Type of siteFreestanding
  • # of employees involved in research4
  • # of investigators4
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • REGULATORY INFORMATION 
  • Contact for regulatory documentsBrian Springer
  • Regulatory phone number(312) 731-6128
  • # of days to turn around regulatory documents3-5
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • FINANCIAL INFORMATION 
  • # days to turn around budget and contract2-3

Contacts